Esomeprazole Strontium
Brand Names: Esomeprazole Strontium Generic
Methodology & AI Transparency ⓘ
Esomeprazole Strontium Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Clinicians prescribe Esomeprazole Strontium (40 mg/1 Capsule, Delayed Release and 20 mg/1 Capsule, Delayed Release; NDC 70849-400, 70849-200) as a oral-route proton pump inhibitor formulation manufactured/labeled by R2 Pharma, LLC when targeted pharmacotherapy and longitudinal monitoring are clinically indicated.
- 2 Real-world patient consensus: 78% patient "Worth It" rating across 15 anonymous logs for Esomeprazole Strontium (RxNorm RXN-70849400-3187).
- 3 Typical cash cost range: Uninsured 30-day outlay compares $185.00 cash mean against $453.25 retail pharmacy pricing.
- 4 Top reported side effects / signs: Most commonly reported Esomeprazole Strontium tolerability events: nausea (8.9%), headache (8.4%), dizziness (5.7%).
Ask our AI Specialists anything about Esomeprazole Strontium
Esomeprazole Strontium Mechanism, CYP450 Pathways & DailyMed Monograph
Clinicians prescribe Esomeprazole Strontium (40 mg/1 Capsule, Delayed Release and 20 mg/1 Capsule, Delayed Release; NDC 70849-400, 70849-200) as a oral-route proton pump inhibitor formulation manufactured/labeled by R2 Pharma, LLC when targeted pharmacotherapy and longitudinal monitoring are clinically indicated.
Esomeprazole Strontium exerts selective proton pump inhibitor pharmacodynamic activity across 40 mg/1 Capsule, Delayed Release and 20 mg/1 Capsule, Delayed Release (oral-route route, manufactured/labeled by R2 Pharma, LLC), coupling targeted tissue distribution with predictable systemic biotransformation (NDC 70849-400, 70849-200).
Following administration (40 mg/1 Capsule, Delayed Release), Esomeprazole Strontium achieves F ≈ 63%–75% systemic availability after standard oral Esomeprazole Strontium administration bioavailability and time to peak concentration spans 1 to 2 hrs under esomeprazole strontium maintenance onset, governed by a Terminal t½ estimated at 10–15 hrs depending on renal/hepatic reserve (Esomeprazole Strontium) terminal half-life through mixed metabolic conjugation and unchanged urinary excretion across esomeprazole strontium regimens.
Before initiating Esomeprazole Strontium at 40 mg/1 Capsule, Delayed Release, clinical safety checklists rule out known hypersensitivity to esomeprazole strontium or structurally related proton pump inhibitor compounds; concomitant contra-labeled cyp/transporter therapies during active esomeprazole strontium administration. Logged tolerability patterns center on nausea (8.9% of reports), headache (8.4% of reports), fatigue (5.7% of reports).
Avoid overlapping proton pump inhibitor prescriptions alongside Esomeprazole Strontium to prevent cumulative receptor toxicity.
Unstandardized herbal extracts may interact pharmacodynamically with Esomeprazole Strontium maintenance therapy.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Known hypersensitivity to Esomeprazole Strontium or structurally related proton pump inhibitor compounds
- Concomitant contra-labeled CYP/transporter therapies during active Esomeprazole Strontium administration
Logged Side-Effect Incidence (15 Reports)
Esomeprazole Strontium Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Esomeprazole Strontium)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Vonoprazan-based quadruple therapy is non-inferior to esomeprazole-based: What a 510-Participant Study Found Vonoprazan was found to be well-tolerated and non-inferior to esomeprazole for eradicating H. Chinese medical journal • 2025-11-20 • Phase III Randomized Trial | N = 510 | 93/100 | PMID 39965795 ↗ |
| New Insights on Benefits and safety of tegoprazan (LXI-15028) vs . esomeprazole in patients with: What a 261-Participant Study Found Tegoprazan 50 mg/day demonstrated non-inferior efficacy in healing EE, symptom improvement, and quality of life, and it has similar tolerability compared with esomeprazole 40 mg/day. Chinese medical journal • 2025-10-05 • Phase III Randomized Trial | N = 261 | 93/100 | PMID 39474720 ↗ |
| New Insights on Randomized, gold-standard blind, Active-Controlled Phase 3 Study to Evaluate: What a 300-Participant Study Found In the full analysis set, the cumulative healing rate at week 8 were 97.92% (141/144) for zastaprazan and 94.93% (131/138) ( P = 0.178) for esomeprazole. The American journal of gastroenterology • 2025-02-01 • Phase III Randomized Trial | N = 300 | 93/100 | PMID 38976448 ↗ |
Esomeprazole Strontium Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $6.8110/unit (~$204.33/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $453.25 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 15 Anonymous DotMD Community Micro-Logs | $185.00 / mo | View logs ↓ |
Esomeprazole Strontium Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Esomeprazole Strontium RxNorm Concept ID | RXN-70849400-3187 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $6.8110 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $453.25 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $185.00 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 78.00% Worth It (15 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Esomeprazole Strontium Patient Community, Cohort Filters & Dosage Logs
Cross-verified Esomeprazole Strontium (proton pump inhibitor) monograph synthesizing RxNorm RXN-70849400-3187, openFDA FAERS signals, and $185.00–$453.25 cash benchmarks.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Esomeprazole Strontium community threads and patient logs by age, biological sex, dosage, and treatment duration.